Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Hydromorphone, Vancomycin and Magnesium Sulfate Now Available from Pentec Health
  • USA - English

Multiple Strengths Available in Snap-N-Go® Vials and Ready to Administer Vials


News provided by

Pentec Health

Aug 28, 2018, 08:00 ET

Share this article

Share toX

Share this article

Share toX

PHILADELPHIA, Aug. 28, 2018 /PRNewswire-PRWeb/ -- Pentec Health, Inc., an established leader in patient-specific and sterile compounding (503A), announced the availability of multiple products using their patented Snap-N-Go® (SNG) vials (Vancomycin and Magnesium Sulfate) as well as ready-to-administer vials (Hydromorphone). Snap-N-Go® products are concentrated, sterile solutions that come in single-dose vials. Each vial delivers a precise dose or desired concentration, which is not available commercially (SNG) when introduced into a diluent bag of choice. In the forward positions, these vials can be stored in automated dispensing machines (ADMs) for rapid retrieval, dose-tracking and subsequent administration to a patient by a nurse utilizing a standard vial-to-bag adaptor/activation process. Pentec Health is now registered to sell these products in 35 states, with Florida and New York being the most recent additions.

The following products are available to order:

Hydromorphone 1 mg/mL (1 mL) Ready-to-Administer Vial (1 mg dose within a 5 mL vial)
Hydromorphone 1 mg/mL (2 mL) Ready-to-Administer Vial (2 mg dose within a 5 mL vial)
Hydromorphone 25 mg/mL (1.2 mL) Snap-N-Go® Vials (30 mg dose within a 5 mL vial)
Hydromorphone 25 mg/mL (2 mL) Snap-N-Go® Vials (50 mg dose within a 5 mL vial)
Hydromorphone 25 mg/mL (4 mL) Snap-N-Go® Vials (100 mg dose within a 5 mL vial)
Hydromorphone 25 mg/mL (8 mL) Snap-N-Go® Vials (200 mg dose within a 10 mL vial)
Hydromorphone 25 mg/mL (10 mL) Snap-N-Go® Vials (250 mg dose within a 10 mL vial)

Vancomycin 100 mg/mL 7.5 mL Snap-N-Go® Vials (750 mg dose within a 20 mL vial)
Vancomycin 100 mg/mL 10 mL Snap-N-Go® Vials (1000 g dose within a 20 mL vial)
Vancomycin 100 mg/mL 12.5 mL Snap-N-Go® Vials (1250 mg dose within a 20 mL vial)
Vancomycin 100 mg/mL 15 mL Snap-N-Go® Vials (1500 mg dose within a 20 mL vial)
Vancomycin 100 mg/mL 17.5 mL Snap-N-Go® Vials (1750 mg dose within a 20 mL vial)
Vancomycin 100 mg/mL 20 mL Snap-N-Go® Vials (2000 mg dose within a 20 mL vial)

Magnesium Sulfate 625 mg/mL (1.6 mL) Snap-N-Go® Vials (1000 mg dose within a 5 mL vial)
Magnesium Sulfate 625 mg/mL (3.2 mL) Snap-N-Go® Vials (2000 mg dose within a 5 mL vial)
Magnesium Sulfate 625 mg/mL (4.8 mL) Snap-N-Go® Vials (3000 mg dose within a 5 mL vial)
Magnesium Sulfate 625 mg/mL (6.4 mL) Snap-N-Go® Vials (4000 mg dose within a 10 mL vial)

Pentec Health's dedicated 503B Outsourcing Facility now enables the company to provide non-patient-specific compounded sterile preparations to hospitals and other institutional pharmacies. It is registered with the U.S. Food and Drug Administration (FDA) as a Human Drug Outsourcing Facility under Section 503B of the Federal Food, Drug, and Cosmetic Act and has been inspected for compliance with that Agency's stringent current Good Manufacturing Practice (cGMP) requirements for both its design and operation.

"Through the insight we gathered from industry experts, we have developed and patented innovative products that change the way sterile preparations are managed and prepared. We have purposely built our 503B facility and our products with Quality and Safety by Design." said Joseph Cosgrove, Chairman, President, and CEO of Pentec Health. Mr. Cosgrove added "With over 35 years of deep expertise in sterile compounding, we continue to focus on bringing much-needed medications to healthcare providers as we eagerly anticipate launching over 50 additional products in the next several months."

Pentec Health proactively provides a Certificate of Analysis (COA) and Certificate of Conformity (COC) detailing each product's purity, potency, sterility, and stability with the receipt of the product.

About Pentec Health
For over 35 years, Pentec Health has been an industry leader in providing patient-specific compounded sterile medications. Pentec Health's medications are used for administration in dialysis centers, as well as providing in-home Specialty Infusion through nursing services and complex pharmaceutical products to patients who require access outside of a hospital setting. Pentec Health has built a tradition of exceptional patient care by committing to quality, safety, and innovation. As a 503B outsourcing facility, we aim to be the provider of choice for outsourced products, sterile preparations and services in the healthcare marketplace. For more information, please visit http://www.pentechealth.com.

Contact
Pentec Health, Inc.
Shetal Vyas
484-480-2279

SOURCE Pentec Health

Related Links

www.pentechealth.com

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.